McKesson Corporation Q2 FY2027 results
$1102.80+2.39%
McKesson Corporation reported revenue of $111.0 billion, up 7.6% from a year earlier, net income of $1.22 billion and diluted earnings per share of $10.44 against $8.92 for the second quarter of fiscal 2027 (the three months to 30 Sep 2026).
From its quarterly report, filed 4 Nov 2026. Compiled and checked by AapWire.
Q2 FY2027 against Q2 FY2026
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q2 FY2027 | Q2 FY2026 | Change |
|---|---|---|---|
| Revenue | $111.0B | $103.2B | +7.6% |
| Gross profit | $3.96B | $3.54B | +11.7% |
| Gross margin | 3.6% | 3.4% | +0.1 pts |
| Operating income | $1.60B | $1.41B | +14.0% |
| Operating margin | 1.4% | 1.4% | +0.1 pts |
| Net income | $1.22B | $1.11B | +9.7% |
| Diluted EPS | $10.44 | $8.92 | +17.0% |
| Operating cash flow | $3.07B | $2.42B | +26.9% |
| Capital expenditure | $65.00M | $106.0M | −38.7% |
| Free cash flow | $3.00B | $2.31B | +29.9% |
Operating KPIs for the quarter
| KPI | Q2 FY2027 | Change on a year |
|---|---|---|
| North American Pharmaceutical revenue | $91.4B | up 5.6% |
| Oncology & Multispecialty revenue | $15.0B | up 24.4% |
| Medical-Surgical Solutions revenue | $3.1B | up 5.1% |
| Prescription Technology Solutions revenue | $1.5B | up 10.5% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q2 FY2027 | 30 Sep 2026 | $111.0B | +7.6% | $10.44 |
| Q1 FY2027 | 30 Jun 2026 | $105.4B | +7.7% | $5.15 |
| Q4 FY2026 | 31 Mar 2026 | $96.30B | +6.0% | $13.69 |
| Q3 FY2026 | 31 Dec 2025 | $106.2B | +11.4% | $9.59 |
| Q2 FY2026 | 30 Sep 2025 | $103.2B | +10.1% | $8.92 |
| Q1 FY2026 | 30 Jun 2025 | $97.83B | +23.4% | $6.25 |
| Q4 FY2025 | 31 Mar 2025 | $90.82B | +18.9% | $10.00 |
| Q3 FY2025 | 31 Dec 2024 | $95.29B | +17.8% | $6.95 |
More on McKesson Corporation: financial statements · revenue · earnings per share
MCK's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
